Evidence map›Paper›PMID 39267505›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

[Risk factors and prognosis of pediatric silent lupus nephritis with class Ⅲ to Ⅴ].

Tian Shen, Qing-Nan He, Qin Zhang, Yan Cao, Xi-Qiang Dang, Xiao-Chuan Wu, Xiao-Yan Li

Abstract readEnglish Abstract
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tian ShenDepartment of Pediatrics, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Qing-Nan He
Qin Zhang
Yan CaoDepartment of Pediatrics, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Xi-Qiang DangDepartment of Pediatrics, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Xiao-Chuan WuDepartment of Pediatrics, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Xiao-Yan LiDepartment of Pediatrics, Second Xiangya Hospital, Central South University, Changsha 410011, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo study the risk factors and prognostic characteristics of pediatric silent lupus nephritis (SLN) with class Ⅲ to V.

methodsA retrospective study was conducted to collect clinical data from 30 children diagnosed with SLN at the Department of Pediatrics, Second Xiangya Hospital, Central South University, from May 2007 to April 2023. Based on renal pathological classification, the patients were divided into a class Ⅱ group (12 cases) and a class Ⅲ to Ⅴ group (18 cases). The risk factors for the occurrence of class Ⅲ to Ⅴ SLN were analyzed, and the prognostic characteristics were summarized.

resultsAmong the 30 SLN patients, the median follow-up time was 61.50 months. There were no statistically significant differences in the proportions of patients who discontinued glucocorticoids or achieved low disease activity status, nor in the annual decline rate of estimated glomerular filtration rate (eGFR) between the class Ⅱ and class Ⅲ to V groups (

conclusionsClass Ⅲ to V SLN is not uncommon among SLN children, and there remains a risk of long-term renal function progression. Being female and having low serum complement C3 levels are identified as risk factors for class Ⅲ to V SLN in children.

Indexed as

Complement C3Lupus NephritisAdolescentChildChild, PreschoolFemaleGlomerular Filtration RateHumansMalePrognosisRetrospective StudiesRisk FactorsComplement C3ChildComplement C3PrognosisRisk factorSilent lupus nephritis

Identifiers

PMID39267505
PMCPMC11404472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.